The Ministry of Chemicals & Fertilizers published the revised framework for Pharmaceutical late on Tuesday, replacing guidelines that had been in force since 2021. The notification runs to 46 pages and touches eligibility thresholds, certification, the incentive claim cycle and the penalty schedule, and it takes effect 48 days after gazette publication.
The next milestone is the release of the operating manual and the online portal, which the ministry says will arrive within six weeks. Until then, firms are advised to rely on the frequently-asked-questions document that accompanied the notification, which already answers 38 of the questions raised during stakeholder consultation.
What the notification changes
Buyers abroad are watching closely. Procurement teams in United Kingdom have asked their Indian suppliers for written confirmation of compliance timelines, and two large importers have reportedly paused new multi-year contracts until the first batch of certificates is issued. That pause, if it lengthens, is the main downside risk to the scheme's export goals.
Infosys, one of the larger beneficiaries of the previous scheme, said it expects to qualify under the new rules without changes to its sourcing but flagged a one-time cost of about $53 million to re-certify two legacy lines. The company noted that the longer-term benefit lies in predictability, because incentive rates are now fixed through 2029.
By the numbers
State governments are expected to follow with complementary measures. Three states have already signalled land and power-tariff concessions for Pharmaceutical clusters that meet the new thresholds, creating what one official called a competition for compliant capacity. The ministry will convene a coordination meeting next month to avoid duplicative incentives.
“Predictability matters more than the headline rate. Boards will commit capital when the rules are fixed for five years.”
Who gains and who is exposed
Legal advisers recommend that firms treat the first 48 days as a mapping exercise: classify every product line against the new definition, identify supplier gaps, and file for provisional certification early. Those who wait for the final operating manual, they warn, may find the first incentive window closing without them.
Source: IGEN Intelligence analysis of industry association surveys data. Illustrative mock data.
The fiscal arithmetic is modest relative to the sector's size. Pharmaceutical contributed an estimated $1.6 billion to exports last year, and the ministry projects that full uptake of the scheme could lift that figure by 28.5% annually by 2029. Independent economists consider the target ambitious but not unreasonable if the certification bottleneck is resolved.
| Product tier | Incentive rate | Local-content floor | Deadline |
|---|---|---|---|
| Tier 1: finished goods | 7.8% | 64% | Q1 FY28 |
| Tier 2: sub-assemblies | 5.1% | 53% | Q3 FY27 |
| Tier 3: components | 7.6% | 53% | Q1 FY28 |
| Tier 4: raw inputs | 8.9% | 63% | Q3 FY27 |
| Tier 5: services | 8.4% | 46% | Q3 FY27 |
The compliance clock
Industry reaction has been measured. A trade body representing 224 member units welcomed the faster approvals but warned that small manufacturers lack the testing capacity to meet the new certification norms before Q2 FY27. It has asked for a 90-day grace period and a shared-laboratory scheme to be notified alongside the rule.
Timeline of key events
- Consultation closes
Industry bodies submit comments on the draft; 224 responses received.
- Cabinet clears scheme
A $1.6 billion outlay is approved with a five-year tenor.
- Gazette notification
Ministry of Chemicals & Fertilizers publishes the final framework and the penalty schedule.
- Portal pilot
Online application window opens for provisional certification.
- First compliance deadline
Units must declare product-line local content at 8.1% or above.
At the centre of the change is a tighter definition of domestic value addition. Units will now need to demonstrate at least 8.1% local content on a product-line basis rather than a plant-wide average, a shift that officials say closes a loophole but that compliance teams describe as the single most expensive part of the rule.
Expert commentary
“A 30-day approval clock is the real incentive here; money delayed is money discounted.”
“Smaller firms are not at a disadvantage on quality; they are at a disadvantage on paperwork and finance.”
“What matters now is execution. The announcements are in place; the next two quarters will show who can deliver.”
What to watch next
The incentive pool is sized at $1.6 billion over five years, front-loaded so that roughly 40 percent is claimable in the first two. Applications will move to a single online window, and the ministry has committed to a 30-day decision clock, down from an average of 74 days under the previous process.
What it means for you
Audit every product line against the new local-content definition and refresh conformity declarations before the first shipment of the new quarter.
Request supplier compliance timelines in writing and consider staggering contract renewals until certificates are issued.
Units already above the threshold gain a cost-of-capital edge; screen for firms with documented domestic supply chains.
Apply early for shared-lab access and provisional certification; lobbying for a grace period is advisable but not a plan.
Companies and leaders in this story
Frequently asked questions
Sources
- Industry association surveys: Member-level compliance and sentiment data
- Reserve Bank of India: Exchange-rate and trade-credit bulletins
- UN Comtrade: Bilateral trade flows by HS code
- Directorate General of Foreign Trade: Export-import policy and public notices
Mock content for demonstration. Names, figures and quotes are illustrative and not real reporting.
